Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Aug 24;58(9):e01134-20.
doi: 10.1128/JCM.01134-20. Print 2020 Aug 24.

Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection

Elizabeth Smith  1 , Wei Zhen  1 , Ryhana Manji  1 , Deborah Schron  2 , Scott Duong  1   2 , Gregory J Berry  3   2
Affiliations
Comparative Study

Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection

Elizabeth Smith et al. J Clin Microbiol. .

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 and has quickly become a worldwide pandemic. In response, many diagnostic manufacturers have developed molecular assays for SARS-CoV-2 under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) pathway. This study compared three of these assays, the Hologic Panther Fusion SARS-CoV-2 assay (Fusion), the Hologic Aptima SARS-CoV-2 assay (Aptima), and the BioFire Defense COVID-19 test (BioFire), to determine analytical and clinical performance as well as workflow. All three assays showed similar limits of detection (LODs) using inactivated virus, with 100% detection, ranging from 500 to 1,000 genome equivalents/ml, whereas use of a quantified RNA transcript standard showed the same trend but had values ranging from 62.5 to 125 copies/ml, confirming variability in absolute quantification of reference standards. The clinical correlation found that the Fusion and BioFire assays had a positive percent agreement (PPA) of 98.7%, followed by the Aptima assay at 94.7%, compared to the consensus result. All three assays exhibited 100% negative percent agreement (NPA). Analysis of discordant results revealed that all four samples missed by the Aptima assay had cycle threshold (Ct ) values of >37 by the Fusion assay. In conclusion, while all three assays showed similar relative LODs, we showed differences in absolute LODs depending on which standard was employed. In addition, the Fusion and BioFire assays showed better clinical performance, while the Aptima assay showed a modest decrease in overall PPA. These findings should be kept in mind when making platform testing decisions.

Keywords: COVID-19; EUA; PCR; SARS-CoV-2; TMA; molecular diagnostics; quantified virus.

PubMed Disclaimer

References

    1. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK, Washington State 2019-nCoV Case Investigation Team. 2020. First case of 2019 novel coronavirus in the United States. N Engl J Med 382:929–936. doi:10.1056/NEJMoa2001191. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. 2020. Coronavirus disease 2019 (COVID-19) situation summary. Centers for Disease Control and Prevention, Atlanta, GA: Updated 19 April 2020 https://www.cdc.gov/coronavirus/2019-ncov/summary.html. Accessed 13 May 2020.
    1. John Hopkins University. 2020. Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering at Johns Hopkins University. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594.... Accessed 18 June 2020.
    1. Centers for Disease Control and Prevention. 2020. Coronavirus disease 2019 (COVID-19): people who are at higher risk for severe illness. Updated 15 April 2020 Centers for Disease Control and Prevention, Atlanta, GA: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-.... Accessed 13 May 2020.
    1. WHO-Joint Mission on Coronavirus Disease. 2020. Report of the WHO-China Joint Mission on Coronavirus Disease. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis.... Accessed 13 May 2020.

Publication types